Nirman Agri Genetics Ltd.
•₹ 29.05-6.14%
2026-08-21
PROS
- Company comfortably covers its interest (308.8x coverage)
- Company converts assets efficiently - asset turnover of 3.5x
CONS
- Operating cash flow has been negative in recent years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | KSCL | 768.90 | 15.85 | 3955.15 | 0.00 | 279.84 | -14.47 | 742.50 | -13.51 | 21.77 | 39.58 |
| 2. | VENKEYS | 1502.25 | 308.04 | 2116.27 | 0.67 | 49.99 | 215.79 | 1118.38 | 29.17 | 11.27 | 6.18 |
| 3. | AVTNPL | 87.15 | 15.84 | 1327.16 | 0.92 | 31.10 | 156.69 | 241.22 | 82.16 | 14.26 | 16.56 |
| 4. | REGAAL | 97.08 | 0.00 | 999.86 | 0.26 | 133.28 | 1369.95 | 2021.49 | 719.85 | 16.91 | 15.33 |
| 5. | BSHSL | 88.72 | 0.00 | 931.00 | 0.00 | 14.30 | 16.56 | 182.57 | 19.37 | 21.19 | 9.39 |
| 6. | NATHBIOGEN | 154.00 | 7.99 | 292.66 | 1.30 | 32.26 | -13.46 | 328.40 | 15.76 | 6.89 | 10.70 |
| 7. | INDOUS | 86.20 | 34.14 | 172.85 | 0.00 | 3.04 | -35.38 | 32.99 | 7.21 | 21.15 | 12.01 |
| 8. | MSL | 145.00 | 19.15 | 159.21 | 0.00 | 3.97 | 1.93 | 61.84 | 25.81 | 12.34 | 9.28 |
| 9. | OSWALSEEDS | 13.30 | 9.96 | 121.66 | 0.00 | 12.27 | 68.60 | 117.08 | 19.53 | 9.88 | 15.65 |
| 10. | NARMADA | 14.44 | 0.00 | 110.77 | 0.00 | 7.54 | — | 222.63 | — | 8.94 | 4.25 |
| 11. | AGRITECH | 101.30 | 0.00 | 60.17 | 0.00 | -3.61 | 61.18 | 0.00 | — | -1.10 | — |
| 12. | NIRMAN | 32.35 | 9.50 | 25.91 | 0.00 | 6.92 | 107.19 | 63.00 | 207.92 | 35.17 | 11.62 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | |
|---|---|---|
| 8 | 18 | |
| 8 | 15 | |
| Operating Profit | 0 | 4 |
| OPM % | 3 | 20 |
| Other Income | 0 | 0 |
| Interest | 0 | 0 |
| Depreciation | 0 | 0 |
| 0 | 4 | |
| Tax % | 18 | 25 |
| Net Profit | 0 | 3 |
| EPS | 1,86,000 | 27,26,400 |
| Dividend Payout % | 0 | 0 |
| Minority Interest | 0 | 0 |
| Share of Associates | 0 | 0 |
| Adjusted EPS | 1 | 11 |
| Minority Interest | 0 | 0 |
| Share of Associates | 0 | 0 |
| Adjusted EPS | 1 | 11 |
Mar 2021
- 8
- 8
- Operating Profit
- 0
- OPM %
- 3
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 18
- Net Profit
- 0
- EPS
- 1,86,000
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2022
- 18
- 15
- Operating Profit
- 4
- OPM %
- 20
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 4
- Tax %
- 25
- Net Profit
- 3
- EPS
- 27,26,400
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -42%
- 1 Year:
- -79%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- Last Year:
- 161%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | |
|---|---|---|
| LIABILITIES | - | - |
| 0 | 3 | |
| Trade Payables | 1 | 2 |
| 1 | 3 | |
| Total Liabilities | 3 | 8 |
| ASSETS | - | - |
| 0 | 1 | |
| 1 | 1 | |
| 0 | 0 | |
| Cash & Bank | 1 | 1 |
| 1 | 5 | |
| Total Assets | 3 | 8 |
| Total Debt | 1 | 2 |
| Net Working Capital | 1 | 4 |
| Contingent Liabilities | 0 | 0 |
| Book Value per Share | 337.10 | 3050.00 |
| Face Value | 10.00 | 10.00 |
| Total Debt | 1 | 2 |
| Net Working Capital | 1 | 4 |
| Contingent Liabilities | 0 | 0 |
| Book Value per Share | 337.10 | 3050.00 |
| Face Value | 10.00 | 10.00 |
Mar 2021
- 0
- Trade Payables
- 1
- 1
- Total Liabilities
- 3
- 0
- 1
- 0
- Cash & Bank
- 1
- 1
- Total Assets
- 3
- Total Debt
- 1
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 337.10
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 337.10
- Face Value
- 10.00
Mar 2022
- 3
- Trade Payables
- 2
- 3
- Total Liabilities
- 8
- 1
- 1
- 0
- Cash & Bank
- 1
- 5
- Total Assets
- 8
- Total Debt
- 2
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 3050.00
- Face Value
- 10.00
- Total Debt
- 2
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 3050.00
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | |
|---|---|---|
| -0 | -0 | |
| Cash from Investing | -0 | -1 |
| Cash from Financing | 1 | 1 |
| 1 | 0 | |
| Free Cash Flow | -0 | -1 |
| OCF / Net Profit | -0.17 | -0.00 |
| Cumulative 5-Year FCF | 0 | 0 |
| OCF / Net Profit | -0.17 | -0.00 |
| Cumulative 5-Year FCF | 0 | 0 |
Mar 2021
- -0
- Cash from Investing
- -0
- Cash from Financing
- 1
- 1
- Free Cash Flow
- -0
- OCF / Net Profit
- -0.17
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.17
- Cumulative 5-Year FCF
- 0
Mar 2022
- -0
- Cash from Investing
- -1
- Cash from Financing
- 1
- 0
- Free Cash Flow
- -1
- OCF / Net Profit
- -0.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.00
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | |
|---|---|---|
| PER SHARE | - | - |
| EPS (₹) | 186.00 | 2726.40 |
| Book Value (₹) | 337.10 | 3050.00 |
| Dividend per Share (₹) | 0.00 | 0.00 |
| Cash EPS (₹) | 0.76 | 10.72 |
| PROFITABILITY | - | - |
| Operating Margin % | 3.04% | 19.92% |
| Net Margin % | 2.39% | 14.83% |
| ROE % | 55.18% | 160.99% |
| ROCE % | 17.19% | 113.54% |
| 7.38% | 51.22% | |
| EFFICIENCY | - | - |
| Debtor Days | 36 | 53 |
| Inventory Days | 26 | 14 |
| Payable Days | 41 | 34 |
| 20 | 34 | |
| FINANCIAL HEALTH | - | - |
| Debt to Equity (x) | 2.94x | 0.67x |
| Interest Coverage (x) | 99.35x | 308.84x |
| 2.08x | 2.43x | |
| GROWTH | - | - |
| Revenue Growth % | 0.00% | 136.27% |
| Operating Profit Growth % | 0.00% | 1449.45% |
| Net Profit Growth % | 0.00% | 1365.81% |
| 0.00% | 0.00% | |
| VALUATION | - | - |
| P/E (x) | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% |
| 0.00x | 0.00x |
Mar 2021
- EPS (₹)
- 186.00
- Book Value (₹)
- 337.10
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.76
- Operating Margin %
- 3.04%
- Net Margin %
- 2.39%
- ROE %
- 55.18%
- ROCE %
- 17.19%
- 7.38%
- Debtor Days
- 36
- Inventory Days
- 26
- Payable Days
- 41
- 20
- Debt to Equity (x)
- 2.94x
- Interest Coverage (x)
- 99.35x
- 2.08x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 2726.40
- Book Value (₹)
- 3050.00
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 10.72
- Operating Margin %
- 19.92%
- Net Margin %
- 14.83%
- ROE %
- 160.99%
- ROCE %
- 113.54%
- 51.22%
- Debtor Days
- 53
- Inventory Days
- 14
- Payable Days
- 34
- 34
- Debt to Equity (x)
- 0.67x
- Interest Coverage (x)
- 308.84x
- 2.43x
- Revenue Growth %
- 136.27%
- Operating Profit Growth %
- 1449.45%
- Net Profit Growth %
- 1365.81%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Mar 2025
Jul 2024
Oct 2023